Drägerwerk stock: mwb research keeps EUR 135.00 for Drägerwerk stock

Published on 10/16/2026 at 17:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk results are due October 29, 2026. Drägerwerk stock costs EUR 95.70 on October 16, 2026, unchanged versus Xetra close.

Analyst target and reporting date

On October 15, 2026, mwb research maintained a EUR 135.00 target for Drägerwerk.
Drägerwerk will publish its quarterly statement on October 29, 2026.
Drägerwerk stock costs EUR 95.70 at Lang & Schwarz on October 16, 2026 at 5:43 p.m. CEST, unchanged versus the Xetra close of October 16, 2026.
Drägerwerk has a P/E ratio of 10.47 and a market capitalization of EUR 1.8 billion.

Schwarzweiß-Reportagefoto eines Feuerwehrmanns mit Atemschutzgerät im Einsatz — Drägerwerk AG & Co. KGaA Sicherheitstechnik Feuerwehrmann Atemschutz dramatischer Einsatz Rauchgebäude DE0005550636, Illustration mit AI erstellt.

mwb research maintained a EUR 135.00 price target for Drägerwerk on October 15, 2026, according to 4investors. The target is 41.07 percent above the EUR 95.70 stock price. Drägerwerk stock was trading at EUR 95.70 at Lang & Schwarz on October 16, 2026 at 5:43 p.m. CEST, unchanged versus the Xetra close of October 16, 2026.

October 29 reporting date

Drägerwerk will publish its quarterly statement on October 29, 2026, the company said in its preliminary third-quarter release dated October 14, 2026. The date gives investors the next scheduled checkpoint for the medical and safety technology group. The release confirmed that the 2026 outlook remains a currency-adjusted revenue increase of 2.00 to 6.00 percent and an EBIT margin of 6.00 to 8.00 percent, according to Deutsche Boerse.

Stock below its yearly high

The 52-week range is EUR 66.00 to EUR 125.40 as of October 16, 2026. At EUR 95.70, the stock is 23.64 percent below the upper end of that range. The market capitalization is EUR 1.8 billion, while the average trading volume is 22,306 shares and the latest volume is 46,027 shares on October 16, 2026.

Valuation and company outlook

Drägerwerk trades at a P/E ratio of 10.47 and has a dividend yield of 2.00 percent as of October 16, 2026. The company reported fiscal-year 2025 revenue of EUR 3.5 billion on its investor-relations page and employs around 16,700 people worldwide, according to Dräger. On October 14, 2026, Drägerwerk had confirmed its 2026 outlook in the preliminary release.

Comparison with peers

Drägerwerk: unchanged, P/E 10.47, market capitalization EUR 1.8 billion
Getinge (Nasdaq Stockholm, SEK): plus 0.93 percent, P/E 26.61, market capitalization SEK 71.3 billion
Fresenius (Xetra, EUR): plus 2.78 percent, P/E 16.39, market capitalization EUR 25.4 billion

Next date for investors

The October 29 reporting date is the next scheduled company event. The combination of a EUR 135.00 analyst target and the unchanged evening quote leaves the next report as the next concrete valuation checkpoint.

Drägerwerk stock was trading at EUR 95.70 at Lang & Schwarz on October 16, 2026 at 5:43 p.m. CEST, unchanged versus the Xetra close of October 16, 2026 (EUR 95.70). The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.